Health Advice

/

Health

Florida's expanding frontier of stem cells, the controversy and the potential

Cindy Krischer Goodman, South Florida Sun Sentinel on

Published in Health & Fitness

FORT LAUDERDALE, Fla. -- During his teen years, Alex Camel-Toueg barely could leave the house due to severe ulcerative colitis symptoms including frequent diarrhea, abdominal pain and cramping.

Hoping experimental stem cell therapy could help, his mother, Jennifer, contacted Dr. Guenther Koehne, chief of stem cell transplantation at the Baptist Health Herbert Wertheim Cancer Institute.

Koehne obtained special permission from the U.S. Food and Drug Administration (FDA) to treat Alex, and the results after his first infusion were immediate.

“It was almost hard to believe,” Jennifer said. “He woke up the next day with energy. He woke up hungry. He didn’t have any stomach pain, and over the next few days, everything improved.”

Driven by major research universities, high retiree demand, and groundbreaking state laws permitting non-FDA-approved treatments, Florida has become a national focal point for stem cell therapy. For thousands of Floridians willing to pay out of pocket or join clinical trials, the state is a real-time testing ground for regenerative medicine —and a high-stakes tug-of-war between proven science and expensive hope.

The research landscape

Across Florida, accredited academic institutions are conducting rigorous, FDA-authorized clinical trials in cardiology, neurology, oncology and orthopedics to bring regenerative medicine into the mainstream. Researchers are investigating whether stem cells can reduce secondary inflammation after hemorrhagic strokes, improve physical performance in aging-related frailty, calm chronic kidney inflammation, restore motor function in Parkinson’s patients and overcome immunotherapy resistance in brain cancer.

At Baptist Health, Koehne successfully has used FDA-authorized stem cell treatments for both ulcerative colitis and Crohn’s disease, and he is now running trials for neuroinflammatory conditions such as ALS and multiple sclerosis.

“To move the field forward, you would want to have clinical trials that are FDA-approved and allow you to really analyze more patients, 30 or 50 patients with the same diagnosis,” Koehne said. “And with that, you get the scientific evidence or a lot of information that you can use and publish.”

Koehne noted that his biggest surprise has been the cells’ potent anti-inflammatory effects. “It will be a very strong new approach for degenerative diseases and inflammatory diseases to be treated with these cells,” he added.

Commercial clinics and market demand

Outside of formal research, a recent Florida law, one of the few in the U.S., allows licensed physicians (MDs and DOs) to administer non-FDA-approved stem cell therapies for orthopedics, wound care and pain management, provided the cells come from accredited, FDA-registered facilities.

From Miami to Tampa, clinics use these treatments for conditions including diabetic foot ulcers, worn joints and partially torn shoulder tendons. Robert Smith, a 67-year-old Boca Raton tennis player with knee pain, wanted to avoid joint replacement surgery and had grown tired of temporary cortisone shots. His orthopedic doctor sourced umbilical-cord-derived cells from an FDA-registered tissue bank and provided documentation showing the cells survived thawing. Smith paid several thousand dollars out of pocket for an ultrasound-guided injection, and within a few months, his pain completely lifted.

Yet while Florida seniors praise these treatments on pickleball courts and in poker rooms, some physicians urge caution.

“There are misnomers,” said Dr. Giorgio Negron, a sports medicine physician at Memorial Healthcare’s Department of Orthopedics. When patients tell him they received a stem cell injection, he digs deeper. “There are different kinds of injections, and that’s why patient education on what exactly they are getting is important.”

Negron considers platelet-rich plasma (PRP) — created from a patient’s own blood — the “gold standard” for musculoskeletal injuries. “There is still a lot of research going on, but when you compare the gold standard with your cellular therapy, we’re not getting as drastic results,” he said.

Still, he notes that cellular therapy can last longer than PRP. “If it works for you and you get more than like six months to one year relief, maybe even longer, two years of relief, that can be a treatment plan that keeps you functional,” Negron said.

Dr. Michael Swartzon, a sports medicine physician with Baptist Health Orthopedic Care, agrees that outcomes shouldn’t be overstated.

“There are physicians who are doing this, and they’re reporting good results,” Swartzon said. “But access to it in Florida doesn’t mean that it is now effective. Symptom improvement is not the same thing as people saying, ‘Well, my tissue regenerated and my cartilage regrew.’

“We don’t have clinical evidence yet,” he said. “All of this is new. I think it’s great that patients have a choice and they can go and learn, as long as they go to a reputable facility that is telling you what they’re doing and collecting the product in a clean and scientific manner.”

Although Swartzon has seen “good to great results” using stem cells from bone marrow and fat, he generally favors PRP because it is far less expensive. “A good amount of evidence is showing that the PRP, for the most part, is just as effective at a fraction of the cost,” he said.

Florida’s longevity and wellness clinics also aggressively market stem cell therapies.

While state law strictly limits live stem cell treatments to orthopedics, wound care and pain management, high-end clinics in Miami and Palm Beach feature general anti-aging treatments on cash-pay menus alongside hyperbaric oxygen chambers and IV drips for tens of thousands of dollars. To work around state restrictions, these practices often tie treatments to qualifying diagnoses like chronic pain or pivot to cell-free exosomes, which are applied topically after microneedling, injected for hair restoration, or given via IV.

 

However, state law does not override federal authority. The FDA classifies umbilical cord cells and exosomes marketed for inflammation, aging, or systemic disease as unapproved biologic drugs, and federal regulators escalated enforcement across Florida throughout 2025 and 2026.

Beware of stem cell differences

Not all stem cell products are equal, and some marketed therapies contain little to no viable cells.

“When we hear stem cells, that’s a generic term,” Koehne said.

Patient-derived stem cells, harvested from bone marrow or abdominal fat, are commonly used for osteoarthritis, rotator cuff tears, cartilage defects and tendon injuries. By contrast, cells derived from placenta or umbilical cords are more potent and more frequently used in clinical research.

Rafael Gonzalez, chief development and science officer at Restem, a Miami-based company with a California lab that develops therapies for autoimmune and inflammatory diseases, said therapeutic value depends heavily on sourcing and handling. Restem collects cells from donor umbilical cord lining and conditions them. “Our cells are about 20 years of biological age. They are grown in a specific way that ages them,” Gonzalez said. “That is the age when your immune system is primed.”

Gonzalez advises patients to verify a product’s origin, research and safety data before treatment. “We have a bunch of research before we release anything out there. But in Florida, you have a Wild West, where people are not even manufacturing these things the right way. If they got inspected, they’d have problems with the FDA for sure.”

Stem cell treatments can be costly. Outside of clinical trials, treatments typically cost $3,000 to more than $10,000 and are rarely covered by Medicare or private insurance.

Travel for stem cell therapy

The country’s most popular athletes fill social media with posts about miraculous results from stem cell treatments abroad.

Because the U.S. restricts labs from culturing and multiplying stem cells outside clinical trials, many Floridians are following athletes’ lead and traveling to countries such as Mexico and Colombia for high-potency doses of 50 million to over 300 million viable cells. Multi-day treatments that bundle high-dose IV infusions, joint injections, exosomes and hyperbaric oxygen often cost $4,000 to $12,000, or more.

Former Florida state Rep. Julio Robaina traveled from Miami to Colombia for stem cell therapy to repair his knee cartilage and avoid replacement surgery.

“These are not the type of stem cell treatments they do in the United States,” he said. “It’s fresh, it goes in there, and it starts immediately doing the job that stem cells are supposed to do — repair and help your body. That’s why they call it regenerative medicine. And it’s incredible.”

Robaina said he paid $25,000 for a five-day stay that included daily full-body infusions and injections in his bicep, shoulder and knee. He has become a big proponent.

“That arm right now is doing awesome. I am able to move it. And before, I sounded like a skeleton when I walked. You would hear crack, crack, crack. That’s gone,” Robaina said. “I will tell you that I’ve had another MRI done, and I can see now where the actual meniscus is starting to grow.”

The road ahead

Robaina believes that, as stem cell therapy becomes more mainstream, demand will grow, the science will advance and prices will fall.

“I would love to get this into the United States because there is no reason why everyone in the United States should not have access to this,” he said.

For Jennifer Camel-Toueg and her son, the benefit is already clear: after six treatments, Alex’s ulcerative colitis is in remission. “His condition has improved dramatically,” Camel-Toueg said. “I don’t think there’s enough out there yet about stem cell therapy, but I think there will be.”

____

South Florida Sun Sentinel health reporter Cindy Goodman can be reached at cgoodman@sunsentinel.com.

____


©2026 South Florida Sun Sentinel. Visit at sun-sentinel.com. Distributed by Tribune Content Agency, LLC.

 

Comments

blog comments powered by Disqus